Full article: Correction

510

Views

CrossRef citations to date

Altmetric

This article refers to:

A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis

Article title: A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis

Authors: Shefner JM, Cudkowicz ME, Hardiman O, Cockroft BM, Lee JH, Malik FI, Meng L, Rudnicki SA, Wolff AA & Andrews JA on behalf of The VITALITY-ALS STUDY GROUP

Journal: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

DOI: http://dx.doi.org/10.1080/21678421.2019.1612922

When this article was first published online, The VITALITY-ALS Study Group was missing. This has now been added in the online version of the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Correction

Information for

Open access

Opportunities

Help and information

Correction

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Your download is now in progress and you may close this window

Login or register to access this feature

Information for

Open access

Opportunities

Help and information

Keep up to date